The term "preformulation studies" refers to research conducted during the early phases of developing therapeutic candidates into various dosage forms. During the preformulation step, these candidates' physical and chemical properties are investigated in order to discover the important features that influence the selection of the most appropriate candidate. Preformulation studies have been demonstrated to play a significant part in the drug discovery and development process since they are frequently used when valuable information about lead identification and optimization is required. Preformulation studies have been reported to be accurate predictors of changes that may occur during the combination process of the active pharmaceutical ingredient (API) with an appropriate delivery method that is meant to deliver the active ingredient to the patient safely and effectively.
Title : Engineered nanomaterial-mediated systemically administered m-RNA-based gene therapy directed exclusively to cancer, present successes and future prospects
A C Matin, Stanford University, United States
Title : Preparation and characterization of fibers made from PCL/PVP-ChAgG, along with exploring their potential as wound dressings
Luis Jesus Villarreal Gomez, Autonomous University of Baja California, Mexico
Title : Liver biopsy handling of metabolic-associated fatty liver disease (mafld): The children's hospital of eastern ontario grossing protocol
Consolato M Sergi, University of Ottawa, Canada
Title : Haptoglobin-related protein without signal peptide as biomarker of renal salt wasting (HPRWSP) in hyponatremia, hyponatremia-related diseases and as new syndrome in alzheimer’s disease
John K Maesaka, NYU Langone Hospital Long Island, United States